BlackRock, Inc.

Holdings History for HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

Symbol: HALO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 12,612,300 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in HALOZYME THERAPEUTICS, INC. Common Stock (HALO)

17 Jul 2025 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12,612,300 shares of HALOZYME THERAPEUTICS, INC. Common Stock (HALO). This represents 10% ownership of the company. In their previous filing dated 28 Apr 2025, BlackRock, Inc. had reported owning 16,144,164 shares, indicating a decrease of +22%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BlackRock, Inc.	10%	-22%	$656,091,846	12,612,300	-3,531,864	-22%	$52.02	13G/A	30 Jun 2025	17 Jul 2025, 19:54
BlackRock, Inc.	13%		$956,541,717	16,144,164			$59.25	13G/A	31 Mar 2025	28 Apr 2025, 17:18

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	+0%	$885,254,609	13,153,857	+293,658	+2.3%	$67.30	Q4 2025
30 Sep 2025	0.02%	-0%	$943,166,956	12,860,199	-339,833	-2.6%	$73.34	Q3 2025
30 Jun 2025	0.01%	-0%	$686,665,663	13,200,032	-3,892,079	-23%	$52.02	Q2 2025
31 Mar 2025	0.02%	-0%	$1,090,647,602	17,092,111	-474,044	-2.7%	$63.81	Q1 2025
31 Dec 2024	0.02%	+0%	$839,837,871	17,566,155	+136,136	+0.78%	$47.81	Q4 2024
30 Sep 2024	0.02%	0%	$997,694,286	17,430,019	0		$57.24	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.